Zherui Wu

1.9k total citations
26 papers, 1.4k citations indexed

About

Zherui Wu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Zherui Wu has authored 26 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Oncology and 8 papers in Immunology. Recurrent topics in Zherui Wu's work include Cancer, Hypoxia, and Metabolism (5 papers), Neuropeptides and Animal Physiology (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Zherui Wu is often cited by papers focused on Cancer, Hypoxia, and Metabolism (5 papers), Neuropeptides and Animal Physiology (5 papers) and Neuroendocrine Tumor Research Advances (4 papers). Zherui Wu collaborates with scholars based in China, France and Italy. Zherui Wu's co-authors include Philippe Icard, Marco Alifano, Hubert Lincet, Ludovic Fournel, Patricia Forgez, Antoine Coquerel, Jean Trédaniel, Jean Martínez, Qianqian Di and Xibao Zhao and has published in prestigious journals such as The Journal of Immunology, Trends in Biochemical Sciences and Clinical Cancer Research.

In The Last Decade

Zherui Wu

26 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zherui Wu China 18 749 395 365 237 165 26 1.4k
Alejandro P. Adam United States 22 720 1.0× 356 0.9× 236 0.6× 258 1.1× 280 1.7× 62 1.7k
Lijing Wang China 20 668 0.9× 178 0.5× 299 0.8× 182 0.8× 119 0.7× 66 1.2k
James E. Esplen United States 11 945 1.3× 392 1.0× 219 0.6× 321 1.4× 186 1.1× 11 1.7k
Soheil Naderi Norway 24 819 1.1× 414 1.0× 166 0.5× 219 0.9× 145 0.9× 59 1.5k
Antonio F. Santidrián Spain 21 1.2k 1.6× 429 1.1× 281 0.8× 153 0.6× 274 1.7× 30 1.8k
Hae‐Yun Jung South Korea 20 823 1.1× 505 1.3× 307 0.8× 268 1.1× 83 0.5× 31 1.5k
Hailin Zhang China 15 562 0.8× 218 0.6× 253 0.7× 128 0.5× 119 0.7× 56 1.1k
Xiaobing Deng United States 24 1.2k 1.6× 436 1.1× 300 0.8× 195 0.8× 73 0.4× 39 1.8k
Zhenyi Ma China 20 867 1.2× 177 0.4× 248 0.7× 256 1.1× 226 1.4× 49 1.4k

Countries citing papers authored by Zherui Wu

Since Specialization
Citations

This map shows the geographic impact of Zherui Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zherui Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zherui Wu more than expected).

Fields of papers citing papers by Zherui Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zherui Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zherui Wu. The network helps show where Zherui Wu may publish in the future.

Co-authorship network of co-authors of Zherui Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Zherui Wu. A scholar is included among the top collaborators of Zherui Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zherui Wu. Zherui Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Xibao, Yue Xiao, Han Wu, et al.. (2023). USP39 Regulates NF-κB–Mediated Inflammatory Responses through Deubiquitinating K48-Linked IκBα. The Journal of Immunology. 210(5). 640–652. 14 indexed citations
2.
Xiao, Yue, Jiazheng Quan, Xibao Zhao, et al.. (2022). Succinate Is a Natural Suppressor of Antiviral Immune Response by Targeting MAVS. Frontiers in Immunology. 13. 816378–816378. 22 indexed citations
3.
Zhao, Xibao, Qianqian Di, Han Liu, et al.. (2022). MEF2C promotes M1 macrophage polarization and Th1 responses. Cellular and Molecular Immunology. 19(4). 540–553. 86 indexed citations
4.
Sun, Ping, Zherui Wu, Yue Xiao, et al.. (2022). TfR-T12 short peptide and pH sensitive cell transmembrane peptide modified nano-composite micelles for glioma treatment via remodeling tumor microenvironment. Nanomedicine Nanotechnology Biology and Medicine. 41. 102516–102516. 15 indexed citations
5.
Ma, Xingyu, Qianqian Di, Xiaoli Li, et al.. (2022). Munronoid I Ameliorates DSS-Induced Mouse Colitis by Inhibiting NLRP3 Inflammasome Activation and Pyroptosis Via Modulation of NLRP3. Frontiers in Immunology. 13. 853194–853194. 23 indexed citations
6.
Wu, Han, Xiaofan Yin, Xibao Zhao, et al.. (2022). HDAC11 negatively regulates antifungal immunity by inhibiting Nos2 expression via binding with transcriptional repressor STAT3. Redox Biology. 56. 102461–102461. 10 indexed citations
7.
Tang, Haimei, Qianqian Di, Xingyu Ma, et al.. (2021). Synthesis compound XCR-7a ameliorates LPS-induced inflammatory response by inhibiting the phosphorylation of c-Fos. Biomedicine & Pharmacotherapy. 145. 112468–112468. 5 indexed citations
8.
Xiao, Yue, Wenjing Ma, Weiwei Hu, et al.. (2021). Ubiquitin‐specific peptidase 39 promotes human glioma cells migration and invasion by facilitating ADAM9 mRNA maturation. Molecular Oncology. 16(2). 388–404. 17 indexed citations
9.
Wu, Zherui, Nicolas Städler, Jin Liu, et al.. (2021). Effect of Monoclonal Antibody Blockade of Long Fragment Neurotensin on Weight Loss, Behavior, and Metabolic Traits After High-Fat Diet Induced Obesity. Frontiers in Endocrinology. 12. 739287–739287. 8 indexed citations
10.
Icard, Philippe, Luca Simula, Zherui Wu, et al.. (2021). Why may citrate sodium significantly increase the effectiveness of transarterial chemoembolization in hepatocellular carcinoma?. Drug Resistance Updates. 59. 100790–100790. 38 indexed citations
11.
Icard, Philippe, Mauro Loi, Zherui Wu, et al.. (2020). Metabolic Strategies for Inhibiting Cancer Development. Advances in Nutrition. 12(4). 1461–1480. 21 indexed citations
12.
Xiao, Yue, Qi Huang, Zherui Wu, & Weilin Chen. (2020). Roles of protein ubiquitination in inflammatory bowel disease. Immunobiology. 225(6). 152026–152026. 21 indexed citations
13.
Icard, Philippe, Hubert Lincet, Zherui Wu, et al.. (2020). The key role of Warburg effect in SARS-CoV-2 replication and associated inflammatory response. Biochimie. 180. 169–177. 103 indexed citations
14.
Icard, Philippe, Ludovic Fournel, Zherui Wu, Marco Alifano, & Hubert Lincet. (2019). Interconnection between Metabolism and Cell Cycle in Cancer. Trends in Biochemical Sciences. 44(6). 490–501. 233 indexed citations
15.
Icard, Philippe, Zherui Wu, Ludovic Fournel, et al.. (2019). ATP citrate lyase: A central metabolic enzyme in cancer. Cancer Letters. 471. 125–134. 168 indexed citations
16.
Wu, Zherui, Ludovic Fournel, Jin Liu, et al.. (2018). Modulation of lung cancer cell plasticity and heterogeneity with the restoration of cisplatin sensitivity by neurotensin antibody. Cancer Letters. 444. 147–161. 16 indexed citations
17.
Liu, Jin, Mikaël Agopiantz, Joël Poupon, et al.. (2017). Neurotensin Receptor 1 Antagonist SR48692 Improves Response to Carboplatin by Enhancing Apoptosis and Inhibiting Drug Efflux in Ovarian Cancer. Clinical Cancer Research. 23(21). 6516–6528. 22 indexed citations
18.
Wu, Zherui, Antoine Galmiche, Jin Liu, et al.. (2016). Neurotensin regulation induces overexpression and activation of EGFR in HCC and restores response to erlotinib and sorafenib. Cancer Letters. 388. 73–84. 29 indexed citations
19.
Wu, Zherui, Jean Martínez, Jean Trédaniel, & Patricia Forgez. (2013). Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy. Frontiers in Endocrinology. 3. 184–184. 94 indexed citations
20.
Vilasco, Myriam, Laudine Communal, Justine Hugon‐Rodin, et al.. (2013). Loss of glucocorticoid receptor activation is a hallmark of BRCA1-mutated breast tissue. Breast Cancer Research and Treatment. 142(2). 283–296. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alejandro P. Adam Breakdown of academic impact, for papers by Lijing Wang Breakdown of academic impact, for papers by James E. Esplen Breakdown of academic impact, for papers by Soheil Naderi Breakdown of academic impact, for papers by Antonio F. Santidrián Breakdown of academic impact, for papers by Hae‐Yun Jung Breakdown of academic impact, for papers by Hailin Zhang Breakdown of academic impact, for papers by Xiaobing Deng Breakdown of academic impact, for papers by Zhenyi Ma
Rankless by CCL
2026